Apart from JIA associated with IEI, TNF-alpha inhibitors have been used with good clinical efficacy in patients with 22q11.2DS with associated IBD and in one patient with XLA with associated pyoderma gangrenosum (8–16). The gene discussed is TNF; the disease is juvenile idiopathic arthritis.